arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

InspireMD, Inc.

NSPR
$0.76 ▲ +0.01 (+0.75%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
60 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
13
Health
Poor
Bearish
auto_awesome

Analytical Summary

InspireMD, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $64.3M
Dividend Yield —
Revenue Growth -0.4% ↘
Op. Margin None
ROIC -36.2% ↘
FCF / Share $-0.13 ↗
Trailing P/E —
Price / Book 1.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 22, 2026.

60-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.77M
— -0.4% —
Net Income Profit after all expenses
$-14.32M
↓ -8.9% —
Operating Margin Operating profit as % of sales
-411.4%
↓ -7.2% —
FCF / Share Free cash flow per share
$-0.13
↑ +11.3% —
Long-Term Debt Long-term obligations
$1.10M
↓ -48.8% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Returns ↓
10
Cash Quality ↓
51

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 16 years · 60 quarters